Systemic immune-inflammatory index and platelet-to-lymphocyte ratio in intrahepatic cholestasis of pregnancy

References

1. 1.↵
   1. Hague WB,
   2. Williamson C,
   3. Beuers U

   . Intrahepatic cholestasis of pregnancy: introduction and overview 2024. Obstet Med 2024; 17: 138-143.

   OpenUrlPubMed
2. 2.↵
   1. Roediger R,
   2. Fleckenstein J

   . Intrahepatic cholestasis of pregnancy. Clin Liver Dis (Hoboken) 2024; 23: e0119.

   OpenUrl
3. 3.↵
   1. Obiegbusi CN,
   2. Dong XJ,
   3. Obiegbusi SC,
   4. Jin X,
   5. Okoene IK

   . Predictors of adverse fetal outcomes in intrahepatic cholestasis of pregnancy (ICP): a narrative review. Reprod Sci 2024; 31: 341-351.

   OpenUrlPubMed
4. 4.↵
   1. Tang M,
   2. Xiong L,
   3. Cai J,
   4. Fu J,
   5. Liu H,
   6. Ye Y, et al.

   Intrahepatic cholestasis of pregnancy: insights into pathogenesis and advances in omics studies. Hepatol Int 2024; 18: 50-62.

   OpenUrlPubMed
5. 5.↵
   1. Kondrackiene J,
   2. Kupcinskas L

   . Intrahepatic cholestasis of pregnancy-current achievements and unsolved problems. World J Gastroenterol 2008; 14: 5781-5788.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Obut M,
   2. Kından A,
   3. Ibanoğlu MC,
   4. Çayönü Kahraman N,
   5. Arat Ö,
   6. Keleş A, et al.

   Liver damage parameters and peripheral blood parameters for prediction and diagnosis of intrahepatic cholestasis in pregnancy. J Obstet Gynaecol Res 2024; 50: 196-204.

   OpenUrlPubMed
7. 7.↵
   1. Luo X,
   2. Li SX,
   3. Hai L,
   4. Liu SW,
   5. Ding XC,
   6. Liu XY, et al.

   [Exploring potential serum metabolite markers of intrahepatic cholestasis based on liquid chromatography-mass spectrometry metabolomics technology]. Zhonghua Gan Zang Bing Za Zhi 2024; 32: 753-760. [In Chinese].

   OpenUrlPubMed
8. 8.↵
   1. Mays JK

   . The active management of intrahepatic cholestasis of pregnancy. Curr Opin Obstet Gynecol 2010; 22: 100-103.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Yayla Abide Ç,
   2. Vural F,
   3. Kılıççı Ç,
   4. Bostancı Ergen E,
   5. Yenidede İ,
   6. Eser A, et al.

   Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers? Turk J Obstet Gynecol 2017; 14: 160-165.

   OpenUrlPubMed
10. 10.↵
    1. Zeng W,
    2. Hou Y,
    3. Gu W,
    4. Chen Z

    . Proteomic biomarkers of intrahepatic cholestasis of pregnancy. Reprod Sci 2024; 31: 1573-1585.

    OpenUrlPubMed
11. 11.↵
    1. Liu W,
    2. Chen L,
    3. Miao K,
    4. You Y,
    5. Li J,
    6. Lu J, et al.

    Identification and validation of diagnostic biomarkers for intrahepatic cholestasis of pregnancy based on untargeted and targeted metabolomics analyses of urine metabolite profiles. BMC Pregnancy Childbirth 2023; 23: 828.

    OpenUrlPubMed
12. 12.↵
    1. Chen J,
    2. Zhang S

    . The role of inflammation in cholestatic liver injury. J Inflamm Res 2023; 16: 4527-4540.

    OpenUrlPubMed
13. 13.↵
    1. İpek G,
    2. Tanaçan A,
    3. Peker A,
    4. Ağaoğlu Z,
    5. Kara Ö,
    6. Şahin D

    . Systemic inflammation response index as a diagnostic and prognostic predictor of intrahepatic cholestasis of pregnancy: a case-control study from a tertiary center. Int J Gynaecol Obstet 2024; 165: 717-722.

    OpenUrlPubMed
14. 14.↵
    1. Silva J,
    2. Magenta M,
    3. Sisti G,
    4. Serventi L,
    5. Gaither K

    . Association between complete blood count components and intrahepatic cholestasis of pregnancy. Cureus 2020; 12: e12381.

    OpenUrl
15. 15.↵
    1. Ozgen L,
    2. Ozgen G,
    3. Karasin SS,
    4. Bayram F

    . Fibrinogen levels and total serum bile acids in intrahepatic cholestasis of pregnancy. J Coll Physicians Surg Pak 2022; 32: 1404-1409.

    OpenUrlPubMed
16. 16.↵
    1. Lagunas-Alvarado M,
    2. Mijangos-Huesca FJ,
    3. Terán-González JO,
    4. Lagunas-Alvarado MG,
    5. Martínez-Zavala N,
    6. Reyes-Franco I, et al.

    [Systemic immune inflammatory index in sepsis]. Medicina Interna de México 2017; 33: 303-309. [In Spanish].

    OpenUrl
17. 17.↵
    1. Ji P,
    2. He J

    . Prognostic value of pretreatment systemic immune-inflammation index in patients with endometrial cancer: a meta-analysis. Biomark Med 2024; 18: 345-356.

    OpenUrlPubMed
18. 18.
    1. Tanacan A,
    2. Uyanik E,
    3. Unal C,
    4. Beksac MS

    . A cut-off value for systemic immune-inflammation index in the prediction of adverse neonatal outcomes in preterm premature rupture of the membranes. J Obstet Gynaecol Res 2020; 46: 1333-1341.

    OpenUrlPubMed
19. 19.↵
    1. Turgut E,
    2. Yildirim M,
    3. Sakcak B,
    4. Ayhan SG,
    5. Tekin OM,
    6. Sahin D

    . Predicting miscarriage using systemic immune-inflammation index. J Obstet Gynaecol Res 2022; 48: 587-592.

    OpenUrlPubMed
20. 20.↵
    1. Kirbas A,
    2. Biberoglu E,
    3. Daglar K,
    4. İskender C,
    5. Erkaya S,
    6. Dede H, et al.

    Neutrophil-to-lymphocyte ratio as a diagnostic marker of intrahepatic cholestasis of pregnancy. Eur J Obstet Gynecol Reprod Biol 2014; 180: 12-15.

    OpenUrlPubMed
21. 21.↵
    1. Uysal NŞ,
    2. Karakaş LA,
    3. Gülümser Ç,
    4. Esin S,
    5. Yanık F

    . Are complete blood count indices different in twins with the diagnosis of intrahepatic cholestasis of pregnancy? J Clin Obstet Gynecol 2020; 30: 85-91.

    OpenUrl